Nomura Asset Management Co. Ltd. Reduces Stock Holdings in Colgate-Palmolive (NYSE:CL)

Nomura Asset Management Co. Ltd. lowered its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 3.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 851,810 shares of the company's stock after selling 27,070 shares during the period. Nomura Asset Management Co. Ltd. owned about 0.10% of Colgate-Palmolive worth $88,426,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Continuum Advisory LLC lifted its stake in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after acquiring an additional 125 shares during the period. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at about $42,000. Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive during the third quarter valued at about $53,000. Prospera Private Wealth LLC bought a new position in Colgate-Palmolive in the third quarter worth about $64,000. Finally, Gradient Investments LLC lifted its holdings in Colgate-Palmolive by 150.4% in the second quarter. Gradient Investments LLC now owns 666 shares of the company's stock worth $65,000 after buying an additional 400 shares during the period. Institutional investors own 80.41% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on CL. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 target price for the company. JPMorgan Chase & Co. boosted their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. StockNews.com raised shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Monday, November 25th. TD Cowen decreased their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Monday, October 28th. Finally, Stifel Nicolaus cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their target price for the company from $105.00 to $101.00 in a research note on Monday, October 28th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of "Moderate Buy" and an average price target of $105.11.

Colgate-Palmolive Trading Down 1.0 %

NYSE CL traded down $0.95 during trading hours on Monday, hitting $93.28. 1,759,874 shares of the company were exchanged, compared to its average volume of 4,371,653. Colgate-Palmolive has a 52 week low of $75.50 and a 52 week high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock has a 50-day moving average price of $96.54 and a 200 day moving average price of $98.66. The stock has a market cap of $76.21 billion, a PE ratio of 27.00, a price-to-earnings-growth ratio of 3.36 and a beta of 0.43.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive's payout ratio is 57.31%.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.37% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.